Scaled Agile, a portfolio company of Eurazeo SE, one of Europe’s leading private equity firms, has acquired Rentouch, a Swiss-based company specializing in software for visualizing agile planning events across multiple agile teams with
Tags :Dieter Gericke
On January 5, 2023, BioVersys announced that the AMR Action Fund has joined existing investors of BioVersys, extending the total proceeds of the Series C round to CHF 32.6 million. The Swiss pharma company represents the first European-based
JBF Finance has announced a public tender offer for all publicly held shares of SIX listed Bobst Group, the parent company of Bobst, one of the world’s leading suppliers of substrate processing, printing and
Kering completed the sale of Sowind Group, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to Sowind’s management. The luxury Group has supported the two Houses in their development, strengthened their positioning
CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
On January 31, 2022, FNZ, a global wealth management platform, has completed the acquisition of Appway, the leader in client onboarding and servicing for financial institutions. Homburger acted as Swiss counsel to FNZ in this transaction. The
Coinbase, a provider of end-to-end financial infrastructure and technology for the cryptoeconomy, has acquired BRD, a crypto wallet firm. Homburger acted as Swiss counsel to Coinbase in this transaction. The Homburger team was led by
CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
FNZ, a global wealth management platform, has agreed to acquire Appway from its founding shareholders and Summit Partners. Appway is a provider of client onboarding and client servicing for financial institutions. The transaction is due
Kohlberg Kravis Roberts & Co (KKR), a global investment firm, and Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, have entered into an agreement where KKR will acquire Biosynth Carbosynth
